openPR Logo
Press release

Liquid biopsy Market 2022 Report Structure, Product Analysis, Future Outlook and Company Profiles to 2030

01-27-2022 03:06 PM CET | Health & Medicine

Press release from: SDKI

Liquid biopsy Market 2022 Report Structure, Product Analysis,

SDKI Inc. published a new report on the liquid biopsy market. This study includes the statistical and analytical approaches needed to grow the liquid biopsy market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-107283

The liquid biopsy market is estimated to grow from a market value of US $ 3.10 billion in 2022 to US $ 17.44 billion by 2031, with a CAGR of 24.1% during the 2022-2031 forecast period.

Liquid biopsy uses liquid samples without the need for costly or invasive procedures. It is a minimally invasive or non-invasive technology that detects molecular biomarkers. These tests have considerable potential for early detection of cancer, monitoring of treatment and recurrence, detection of fetal genetic abnormalities, and graft rejection in transplant patients. The National Cancer Institute estimates that about 1.6 million new cancer cases have been diagnosed in the United States, and 595,690 died of cancer in 2016. According to the Canadian Cancer Society, there were 202,400 new cancer cases in 2016, with an estimated 78,000 deaths.

The increasing priority of non-invasive liquid biopsy tests over invasive tissue biopsies, as well as the elderly leading to increased global cancers and chromosomal abnormalities, is the main driver of growth in the liquid biopsy market during the forecast period. Is a factor. Emerging markets are also expected to grow at a rapid pace during the forecast period. This is due to increased prevalence of illness, medical awareness, and increased medical costs. However, the lack of sensitivity and specificity of liquid biopsy testing, the high cost of testing at less reimbursement facilities, and the lack of trained professionals will curb the growth of the liquid biopsy market between 2022 and 2031. There is a possibility.

Report sample URL

https://www.sdki.jp/sample-request-107283

Liquid biopsy market segment

The liquid biopsy market is available by biomarker type (circulating tumor cell (CTC), acellular DNA (cfDNA), extracellular vesicles, etc.), sample type (blood, etc.), application (cancer and non-cancer applications), It is divided by end user (hospital / reference laboratory, academic research institution, etc.) and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Based on the type of biomarker, the global liquid biopsy market is divided into circulating tumor cells (CTC), acellular DNA (cfDNA), extracellular vesicles, and more. The cell-free DNA (cfDNA) segment is the largest segment in 2016. This is due to its wide range of uses in prenatal testing, transplant diagnosis, and oncology.

Regional Overview of the Liquid Biopsy Market

In 2020, the North American region had the largest share of the liquid biopsy market. A large share of the region could be due to easy access to technologically advanced equipment, highly developed medical systems in the United States and Canada, and the presence of many major national clinical laboratories. Meanwhile, the Asia Pacific liquid biopsy market is expected to witness the largest CAGR during the forecast period. This is due to increased disposable income, increased government initiatives to modernize medical infrastructure, and increased medical costs.

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Singapore, Other Asia Pacific); Latin America (Brazil, Mexico, Argentina, etc.) Latin America); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy) , Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.

For more information on the survey report

https://www.sdki.jp/press-details/liquid-biopsy-market/362

Leading Key Players in the Liquid Biopsy Market

The leading key players in the liquid biopsy market are Biocept, Inc, F-Hoffmann-la Roche, Illumina, Inc, Natera Inc, Trovagene Inc., Qiagen NV, Laboratory. Corporation of America Holdings, Beijing Genomics Institute, Guardant Health, Inc., Genomic Health, MDx Health SA, Guardant Health, Inc., Myriad Genetics, Inc. and more. The study includes a detailed competitive analysis of these major companies in the liquid biopsy market, corporate profiles, recent developments, and key market strategies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liquid biopsy Market 2022 Report Structure, Product Analysis, Future Outlook and Company Profiles to 2030 here

News-ID: 2539365 • Views: 201

More Releases from SDKI

Defoamer Market-Product, Application and Region-Analysis, Sharing, Trends, Sizes …
SDKI Inc. is a defoamer market survey aimed at providing a detailed analysis of several aspects of the market, including market growth drivers, opportunities, recent trends and challenges between 2014 and 2025. Report sample URL https://www.sdki.jp/sample-request-53417 The defoamer market reached US $ 2.88 billion in 2017 and is expected to grow at a CAGR of 4.5% during the forecast period. Defoamers are widely used to destroy existing foam by destabilizing it. The unique surface
02-16-2022 | Health & Medicine
SDKI
Pharmaceutical Robot Markets-Products, Applications and Regions-Analysis, Sharin …
SDKI Inc. published a new report on the pharmaceutical robot market. This study includes the statistical and analytical approaches needed to grow the pharmaceutical robot market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth. Report sample URL https://www.sdki.jp/sample-request-53416 The pharmaceutical robot market reached
02-16-2022 | Health & Medicine
SDKI
Western blotting market-by product (consumables and equipment), by application ( …
SDKI Inc. published a new report on the Western Blotting Market-Analysis, Shares, Trends, Sizes, and Forecasts 2014-2025. This study includes the statistical and analytical approaches needed to grow the Western blotting market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth. Report
02-16-2022 | Health & Medicine
SDKI
Veterinary Endoscopy Market-By Product Type, By Procedure, By Animal, By End Use …
SDKI Inc. aims to provide a detailed analysis of several aspects of the market, including market growth drivers, opportunities, recent trends and challenges between 2018-2023. Report sample URL https://www.sdki.jp/sample-request-109987 The veterinary endoscope market is estimated to reach US $ 219.0 million by 2023 from US $ 159.8 million in 2018 and is expected to grow at a CAGR of 6.5% during the forecast period. Increasing the use of endoscopes in the diagnosis

All 5 Releases


More Releases for Liquid

Liquid Biopsy Market
Liquid biopsies are non-invasive blood tests that detect tumor DNA & RNA fragments and circulating tumor cells (CTCs), which are released into the blood from the primary tumors and metastatic sites. It is a minimally invasive technology for the detection of molecular biomarkers, excluding expensive or invasive procedures. The global liquid biopsy market accounted for $634 million in 2016, and is estimated to reach
Liquid Applied Membranes Market 2025 |
Liquid Applied Membrane (LAM) is a lowly thickness waterproofing film that is employed in the form of a liquid covering to vertical along with horizontal surfaces. The LAM is, in addition, believed as a cutting-edge waterproofing chemical as well as its solid, consistent property, in addition to the ability to comply with each setup is making its need increase in the worldwide construction industry. Utilization of terrible value construction material
Liquid Milk Market
https://www.qandqmarketresearch.com/reports/7239773/liquid-milk-market-98 In 2017, the global Liquid Milk market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Liquid Milk market based on company, product type, application and key regions. This report studies the global market size of Liquid Milk in key regions like North America, Europe, Asia
Liquid Productions announces name change
13 years since it’s foundation, top creative content production agency Liquid Productions is evolving, with a new name to match a new vision. As of the 10th October the new name for the business is LIQUONA. Repeatedly ranked by industry magazine Televisual as a Top 50 UK corporate production company, LIQUONA has grown from a bedroom startup video production company, to a full creative moving image agency. The name change reflects the development of
Liquid Biopsy Market - Insights
Liquid biopsy involves testing of the blood to identify biomarkers or cancer cells in the form of cells or pieces of DNA which are separated from the tumor and are circulating in the blood. Liquid biopsy helps in early detection of cancer, which would aid in adopting an optimal treatment plan. It is a non-invasive technique, which makes frequent testing possible, and effectiveness of cancer treatment can also be validated
Global Liquid Nitrogen Market 2017
Global Liquid Nitrogen Report 2017 Major Manufacture Analysis Of Liquid Nitrogen Market 2017. The report presents a Depth Research of the market growth factors and drivers. A Deep research of the Liquid Nitrogen Market limitations and the opportunities enable the user to make the future projection. The report also includes Company Profile, based on the manufacturing methods, technological advancements, and innovations. GET SAMPLE REPORT @ https://www.reportsmonitor.com/request-sample/?post=398982 The report has been prepared based